Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis

被引:111
作者
Minoo, P.
Baker, K.
Goswami, R.
Chong, G.
Foulkes, W. D.
Ruszkiewicz, A. R.
Barker, M.
Buchanan, D.
Young, J.
Jass, J. R.
机构
[1] McGill Univ, Dept Pathol, Montreal, PQ H3A 2B4, Canada
[2] Jewish Gen Hosp, SMBD, Dept Human Genet, Montreal, PQ, Canada
[3] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[4] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[5] Jewish Gen Hosp, Dept Med Genet, SMBD, Montreal, PQ, Canada
[6] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[7] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
关键词
D O I
10.1136/gut.2005.082859
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Hyperplastic polyposis of the colorectum is a precancerous condition that has been linked with DNA methylation. The polyps in this condition have been distinguished from typical small hyperplastic polyps and renamed sessile serrated adenomas. Sessile serrated adenomas also occur sporadically and appear to be indistinguishable from their counterparts in hyperplastic polyposis. Aims and methods: The existence of distinguishing molecular features was explored in a series of serrated polyps and matched normal mucosa from patients with and without hyperplastic polyposis by assessing mutation of BRAF, DNA methylation in 14 markers (MINTs 1, 2 and 31, p16, MGMT, MLH1, RASSF1, RASSF2, NORE1 (RASSF5), RKIP, MST1, DAPK, FAS, and CHFR), and immunoexpression of MLH1. Results: There was more extensive methylation in sessile serrated adenomas from subjects with hyperplastic polyposis (p < 0.0001). A more clearcut difference in patients with hyperplastic polyposis was the finding of extensive DNA methylation in normal mucosa from the proximal colon. Conclusions: A genetic predisposition may underlie at least some forms of hyperplastic polyposis in which the earliest manifestation may be hypermethylation of multiple gene promoters in normal colorectal mucosa. Additionally, some of the heterogeneity within hyperplastic polyposis may be explained by different propensities for MLH1 inactivation within polyps.
引用
收藏
页码:1467 / 1474
页数:8
相关论文
共 70 条
[1]   Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours [J].
Agathanggelou, A ;
Honorio, S ;
Macartney, DP ;
Martinez, A ;
Dallol, A ;
Radar, J ;
Fullwood, P ;
Chauhan, A ;
Walker, R ;
Shaw, JA ;
Hosoe, S ;
Lerman, MI ;
Minna, JD ;
Maher, ER ;
Latif, F .
ONCOGENE, 2001, 20 (12) :1509-1518
[2]   The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer [J].
Akino, K ;
Toyota, M ;
Suzuki, H ;
Mita, H ;
Sasaki, Y ;
Ohe-Toyota, M ;
Issa, JPJ ;
Hinoda, Y ;
Imai, K ;
Tokino, T .
GASTROENTEROLOGY, 2005, 129 (01) :156-169
[3]  
[Anonymous], 2000, PATHOLOGY GENETICS T
[4]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[5]  
Biemer-Hüttmann AE, 2000, CLIN CANCER RES, V6, P1909
[6]   CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype [J].
Brandes, JC ;
van Engeland, M ;
Wouters, KAD ;
Weijenberg, MP ;
Herman, JG .
CARCINOGENESIS, 2005, 26 (06) :1152-1156
[7]   CpG island methylation in aberrant crypt foci of the colorectum [J].
Chan, AOO ;
Broaddus, RR ;
Houlihan, PS ;
Issa, JPJ ;
Hamilton, SR ;
Rashid, A .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05) :1823-1830
[8]   Concordant CpG island methylation in hyperplastic polyposis [J].
Chan, AOO ;
Issa, JPJ ;
Morris, JS ;
Hamilton, SR ;
Rashid, A .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (02) :529-536
[9]   The dark side of Ras: regulation of apoptosis [J].
Cox, AD ;
Der, CJ .
ONCOGENE, 2003, 22 (56) :8999-9006
[10]  
Dammann R, 2001, CANCER RES, V61, P3105